This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More

Pharma Grade Synthetic Camphor Market

Pharma Grade Synthetic Camphor Market by Product– By Formulation (Topical, Inhalation), By Application (Respiratory Disorders, Muscular Rheumatism, Counterirritant and Antipruritic, Others), By Distribution Channel (Conventional B2B, Online B2B), and by Region, forecast for 2022 – 2028

Pharma Grade Synthetic Camphor Market by Product– By Formulation (Topical, Inhalation), By Application (Respiratory Disorders, Muscular Rheumatism, Counterirritant and Antipruritic, Others), By Distribution Channel (Conventional B2B, Online B2B), and by Region, forecast for 2022 – 2028

Pharma Grade Synthetic Camphor Market - Analysis, Outlook, Growth, Trends, Forecasts

Pharma Grade Synthetic Camphor Market Snapshot

[253 Pages Report] Global Pharma Grade Synthetic Camphor Market is projected to register the growth of 4.2% CAGR from 2022 to 2028, with an estimated market value of around US$ 532.0 Mn in 2028.

Market Outlook:

Data Points

Market Insights

Pharma Grade Synthetic Camphor Market Value- Base Year 2021

US$ 398.3 Mn

Pharma Grade Synthetic Camphor Market Value- Estimate Year 2022

US$ 415.4 Mn

Pharma Grade Synthetic Camphor Market Value- Projected Year 2028

US$ 532.0 Mn

CAGR 2022-2028

4.2%

Share of top 5 Countries

58.3%

Key Players

Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited, Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd., Rochem International, Inc., Spectrum Chemical Mfg. Corp., Aldon Corporation, Prinova Group LLC., Fengchen Group Co., Ltd., and Others  (100% Market Share)

As per Future Market Insights’ projections, the topical product holds a substantial share of over 71.5% in 2021 in the overall pharma grade synthetic camphor market.

This surge in use of private labelled topical products containing camphor, increasing rate of self-medication among patients and availability of over-the-counter (OTC) drugs and economic growth is been expected to aid the recovery in certain commodity exports such as camphor.

The global upswing in the investment thus, enthusing the major recovery in mature markets is been witnessed as a critical market driver for the pharma grade synthetic camphor market. However, the shift of positive market sentiments in developing economies, partial recovery in commodity prices are the factors, which are aiding the growth of the market.

2016-2021 Pharma Grade Synthetic Camphor Demand Outlook Compared to 2022-2028 Forecast

The global pharma grade synthetic camphor market had witnessed a turnaround growth from 2016 onwards, the trend is been expected to continue over the forecast period, which will drive the demand for pharma-grade synthetic camphor. In addition, the incidence rate of several infectious disease is increasing globally. Indications such as respiratory diseases and sexually transmitted diseases are increasing at an alarming rate in countries across the globe.

Highly populated regions such as APAC, MEA and Latin America have high incidence and prevalence of infectious diseases, which in turn is increasing the demand for camphor containing treatment products for infectious disease. Also, surge in use of private labelled topical products containing camphor, which is been driven by positive consumer sentiment and growing demand for topical pain management products are the other factors which are driving the growth of the pharma-grade synthetic camphor market.

The global pharma grade synthetic camphor market constitutes nearly 4.4% of the US$ 9 Bn pharmaceutical excipients market globally in 2021.  Private-labelled industry witnessing immense growth in the U.S. market, is been driven by positive consumer sentiment towards such products.

Hence, the demand outlook for pharma grade synthetic camphor market stands expected to grow rapidly during the forecast period from 2022- 2028. The pharma grade synthetic camphor market is expected to expand at a considerable growth rate of around CAGR 4.2%, and observe an incremental $ opportunity of USD 116.6 Mn from 2022 to 2028.

What are the Key Opportunities for Market Players?

With increasing diseases burden of influenza, the existing cases occurrence owing to the pandemic and market penetration of the players to increase the product accessibility are the factors that are contributing to the growth of the pharma grade synthetic camphor market.

For meeting the increasing demand, the key players are developing new products and expansions both, geographically and by enhancing their product portfolio.  

  • For instance, In April 2018, Rochem announced a strategic partnership with Changzhou Sunlight Pharmaceutical Co., Ltd. (Sunlight) for new product development and explore finished products in the China market.
  • In Dec 2017, Spectrum Pharmacy Products signed an agreement with Federation of Pharmacy Networks to provide its products at discounted rates.

Thus, it offers a great opportunity to the manufacturers of the pharma grade synthetic camphor during the forecast years.

What are the key challenges to pharma grade synthetic camphor Market?

The Raw material cost makes up approximately 34–40% of the camphor cost and thus access to high quality raw material at stable prices form a very important aspect of business success

Thus, growing prices of raw materials, i.e., alpha pinene or turpentine oil is a major challenge for the manufacturers of pharma grade synthetic camphor. Fluctuation in the exchange rates is expected to adversely affect the business and hamper the growth of the pharma grade synthetic camphor market. Additionally, regulatory restrictions for use of camphor in pharmaceutical products due to its restricted usage in analgesics will also impede the growth of the market in other product segments.

What is the Impact of the COVID-19 Crisis on the Market?

The COVID-19 outbreak initially affected the pharma grade synthetic camphor market negatively due to the lockdowns imposed in the first half of 2020, which resulted in disruption of the supply chain. While after the upliftment of the lockdown, as a prevention measure to avoid contracting the disease, the upward sale of the over the counter topical formulation products have been registered and trend of stocking of the products were also noted in the market owing to the disease COVID-19.

After facing series of challenges such as supply chain disruption, demand fluctuations and other pressing concerns during 2020, the companies are reviewing their long-term strategies to develop adequate crisis-management strategies that place a premium on next-generation products and solutions pharma grade synthetic camphor.

The R&D funding are being reduced modestly, market trends for pharma grade synthetic camphor are constantly being monitored and companies are also launching marketing initiatives with care, as well as long-term contracts are being strengthened to emerge stronger in the post-COVID pandemic scenario.

However, with the opening of all the economies and the people now adapting to the new normal, the pharma grade synthetic camphor market is been expected to achieve significant growth during the forecast period.

Country-wise Insights

Will the U.S. Remain a Key market for Pharma Grade Synthetic Camphor?

The U.S. is the leading country of the North American region with a total market share of 93.6% in 2021 and projected to continue commanding the high growth during the coming years from 2022- 2028 in pharma grade synthetic camphor market owing to its due to high value and high margins in the market. The growing practice of self-medication with OTC products, increased awareness among the masses for alternative medicine for general flu (symptomatic influenza) and related diseases is set to drive the market during the forecast period.

For instance, as per Centre for Disease Control, the annual incidence of flu cases in the U.S. was 35 million, leading to 380,000 hospital admissions during 2019-2020 year.

Why is Germany Considered a More Lucrative Market within Europe?

In the year 2021, Germany dominates the European market of pharma grade synthetic camphor, with a share of over 23.6% throughout the forecast period owing to the increasing demand of pharma-grade synthetic camphor. According to the World Health Organization (WHO), In Germany, yearly influenza epidemics lead to serious disease and death in high-risk populations. A 30–40 % rate of all influenza cases reported yearly is accounted to occur in the children.

The presence of efficient healthcare infrastructure and the key players in the country are supporting the growth of pharma grade synthetic camphor market growth.

Why is India an Emerging Market for Pharma Grade Synthetic Camphor?

India holds over 55% revenue share in the global market in the year 2021, and projected to expand at a CAGR of 5.4% during the forecast period of 2022-2028. It is been reported that, during 2018-19, Influenza infection in India was estimated as 132 per 1000 child-years. The patient’s positive for influenza in outpatients and inpatients were estimated to be 11.2% and 7.1% (respectively. A total influenza cases during 2018 as 16,009,207 in India. Influenza accounted for 10,913,476 outpatient visits and 1, 09,431 hospitalizations. The high incidence of the disease and deeper penetration of the key players and market accessibility of the products is aiding the growth of pharma grade synthetic camphor market.

What is the Outlook in China for the Pharma Grade Synthetic Camphor?

In 2021, China has considerable share in the global pharma grade synthetic camphor market of around 13.1% share by value and is projected to expand at a CAGR of 6.1% from 2022-2028. This is predominantly due to the rising number of influenza cases, for instance, as per the recent estimates, influenza-associated mortality rate was found the highest among adults aged ≥ 65 years, the highest influenza disease burden found among people aged ≥ 65 years and < 5 years in China, while the vaccination coverage in the Chinese population was only approximately 2%.

Furthermore, the miniscule penetration of vaccination among the target population poses the risk of infection transmissibility; hence in turn supporting the demand for pharma grade synthetic camphor in the market.

Category-wise Insights

Which Pharma Grade Synthetic Camphor Formulation is driving the market growth?

By Formulation type, the topical segment accounts for more than 70% market and is expected to expand at a CAGR of 4.4% during the forecast period from 2022 - 2028. 

The topical Product benefits brings direct application on the skin, hence promoting greater absorption, relief from the nasal irritation, reduced side effects and toxicity to other organs and imparting soothing effect. Owing to its natural benefits, it will continue to be the most preferred product among the patients and resulting in growth of pharma grade synthetic camphor market during the forecast period of 2022-2028.

Why does the Respiratory Disorders hold a High Market Share?

The applications of pharma grade synthetic camphor in treating respiratory disorders is highly preferred and records the share of around 28.6% of the global revenue share in 2021. This trend is expected to continue to grow during the study period. The high share of this segment is attributable to the influenza cases, which affects the respiratory channels of the patients, hence promoting the usage of the synthetic camphor enabled products to be administered in the respiratory cases

Which Distribution Channel is leading the Global Pharma Grade Synthetic Camphor Market?

Based on the distribution channel, conventional B2B is the leading segment, with nearly 86.5% market share in 2021 due to its improved efficiency, improved awareness, enhanced analytics, and customer-centric experience. Additionally the patients choose OTC product purchases to be conducted at the pharmacies, hence, the significance of the mode of sale channel will maintain its relevancy in the forecast period of 2022-2028 and support the growth of pharma grade synthetic camphor market growth.

Competitive Landscape

The growing share of over the counter purchase and increasing availability of the products at multiple sales channels are the key strategies adopted by manufacturers and integrators for increasing the consumer base in different geographies.

Additionally, Key players are focusing on expansion of their brands and technology in emerging regions by strategic partnerships, and collaborations to strengthen their market presence.

For instance,

  • In Jan 2017, Merck completed the acquisition of BioControl Systems Inc. to strengthen its position in food safety testing.
  • In Aug 2016, Merck opened a new pharmaceuticals manufacturing plant in Nantong, China. These strategic investments further support Merck's expansion in China

Scope of the Report

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

USD Million for Value, Units for Volume

Key Countries Covered

U.S., China, India, Japan, Brazil, Germany, France, U.K., Mexico, South Africa,  Italy, Canada, Argentina, Australia & NZ, Spain South Korea, India, ASEAN, Australia, New Zealand, South Africa, and GCC Countries

Key Segments Covered

Formulation type, applications, distribution channel and Region

Key Companies Profiled

  • Merck KGaA,
  • Oriental Aromatics Limited,
  • Saptagir Camphor Limited,
  • Mangalam Organics Limited,
  • Nippon Fine Chemical Co., Ltd.,
  • Rochem International, Inc.,
  • Spectrum Chemical Mfg. Corp.,
  • Aldon Corporation
  • Prinova Group LLC. and
  • Fengchen Group Co., Ltd

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Sign Up with MarketNgage

World's Most Profilic Intelligence Engine

Get Access To The World's Largest Market Research Database.

Sign Up Now

Pharma Grade Synthetic Camphor Market Segmentation - by Category

By Formulation Type:

  • Topical
  • Inhalation

By Application:

  • Respiratory Disorders
  • Muscular Rheumatism
  • Counterirritant and Antipruritic
  • Others

By Distribution Channels:

  • Conventional B2B
    • Tenders
    • Direct Procurement
    • Wholesalers & Distributors
  • Online B2B
    • Internal Channel
    • External Channel

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APECJ
  • Japan
  • China
  • Middle East & Africa

Key Questions Answered in the Report

How much is the market for Pharma Grade Synthetic Camphor worth?

The pharma grade synthetic camphor market is worth at US$ 398.3 Mn in the year 2021 and expected to reach US$ 532.0 Mn by 2028.
Pharma Grade Synthetic Camphor is projected to reflect high demand in the forecast period with a CAGR of 4.2%.
Increasing burden of influenza in both developed and developing countries, increasing role of emerging markets of Latin America, APECJ and China as a leader in global production capacity for pharma-grade synthetic camphor are some of the key trends that will fuel the demand for pharma grade synthetic camphor.
Rising adoption of pharma grade synthetic camphor products in abatement of respiratory disorders, and increase in the number of incidence of influenza cases are the major driving factors.
The cumulative market share of the top players constitutes nearly 58.3% of the overall global market share.
U.S., China, India, Japan and Brazil are the top 5 countries which are driving the demand for Pharma Grade Synthetic Camphor.
Western Europe’s market is forecasted to grow at a CAGR of 3.1% between 2022- 2028. Germany being dominant country in term of revenue in European market of pharma grade synthetic camphor.
The Asia Pacific market is set to exhibit a CAGR of over 4.6% during the forecast period.
Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited, Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd., Rochem International, Inc., Spectrum Chemical Mfg. Corp., Aldon Corporation, Prinova Group LLC, and Fengchen Group Co., Ltd. are the key producers in this market.

Need specific information?

Our Clients

Healthcare

View All Reports from Healthcare

View Reports

Recommendations

Healthcare

Orthopedic Braces And Support Market

Published : 2020-07-30

Healthcare

Ankylosing Spondylitis Treatment Market

Published : 2020-08-13

Healthcare

Glp 1 Receptor Agonist Market

Published : 2020-08-13

Healthcare

Preparative And Process Chromatography Market

Published : 2020-08-13